Cargando…
Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), one of the leading causes of cancer deaths in the world, is offering a challenge to human beings, with the current modes of treatment being a palliative approach. Lack of proper curative or preventive treatment methods encouraged extensive research around the world wi...
Autores principales: | Chauhan, Ranjit, Lahiri, Nivedita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933537/ https://www.ncbi.nlm.nih.gov/pubmed/27398029 http://dx.doi.org/10.4137/BIC.S34413 |
Ejemplares similares
-
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
por: Debes, José D., et al.
Publicado: (2021) -
Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma
por: Mehra, Mrigaya, et al.
Publicado: (2017) -
Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
por: Citores, Maria J, et al.
Publicado: (2019) -
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
por: Chauhan, Ranjit, et al.
Publicado: (2018) -
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)